Navigation Links
Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure

New York, New York (PRWEB) May 20, 2013

The nationwide law firm of Bernstein Liebhard LLP notes that a new study has found that magnetic resonance imaging (MRI) can be used to predict metal-on-metal hip replacement failure, regardless of whether or not patients are experiencing symptoms. According to an article published on May 15th in the Journal of Bone & Joint Surgery, MRI detected synovitis (tissue damage) in 68% of asymptomatic patients screened. In patients suffering symptoms due to mechanical causes, the detection rate was 75%, while MRIs were able to detect damage in 78% of patients reporting unexplained pain.*

“This study is encouraging. Any tool that can help detect failing metal-on-metal hip implants at the earliest stage possible is an important step forward in helping those suffering complications due to these products,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently representing clients in several metal-on-metal hip replacement litigations, and continues to offer free legal evaluations to alleged victims of these devices.

Metal-on-Metal Hip Implant Complication
Metal-on-metal hip implants have been the subject of safety concerns since the August 2010 DePuy ASR hip recall.** Since 2011, the U.S. Food & Drug Administration (FDA) has been reviewing the safety of all-metal hips, amid concerns that metal ions shed from such devices could lead to serious complications, including the formation of psuedotumors, metallosis, and early device failure. In January, the agency issued new guidance for patients fitted with these types of implants, advising doctors to consider metal ion testing in those experiencing symptoms of hip implant failure. The FDA also proposed stricter regulations for such devices that would, if adopted, require the manufacturers of metal-on-metal hip replacements currently on the market to conduct post-market safety studies in order to keep selling them.***

According to The New York Times, Johnson & Johnson announced last week that it would stop selling metal-on-metal hip implants, including an all-metal version of the DePuy Pinnacle hip replacement, which is currently the subject of thousands of lawsuits. The company cited both decreased demand for all-metal hips, as well as the recent FDA action, for its decision.****

Bernstein Liebhard LLP is representing hundreds of alleged victims of the DePuy ASR hip recall in a multidistrict litigation now underway in U.S. District Court, Northern District of Ohio. In addition, (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – MDL 2197) Firm partner, Jeffrey S. Grand, is also serving on the Plaintiffs’ Steering Committee for a second multidistrict litigation established in U.S. District Court, Northern District of Texas for metal-on-metal DePuy Pinnacle hip replacement lawsuits. (In re: DePuy Orthopaedics, Inc. Pinnacle Hip Implant Products Liability Litigation - MDL No. 2244)

The Firm is also actively filing claims in the Biomet M2a Magnum hip implant litigation underway in U.S. District Court, Northern District of Indiana (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391). Bernstein Liebhard also represents plaintiffs in a multicounty litigation now moving forward in New Jersey Superior Court for lawsuits filed in the wake of the Stryker hip recall for Rejuvenate and ABG II hip stems. (In re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296) The Firm is also representing individuals who allegedly suffered complications due to the Wright Conserve hip replacement, as well as the Wright Profemur hip implant.

Hip recipients who have allegedly suffered metallosis, hip implant failure, and other serious complications allegedly associated with metal-on-metal hip replacements may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. For more information on filing a metal-on-metal hip implant lawsuit, please visit Bernstein Liebhard’s website. To arrange for a free case review, please contact one of our attorneys today by calling 800-511-5092.


About Bernstein Liebhard
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients
2. DePuy Announces It Will Stop Selling Metal-On-Metal Hip Implants, Notes Rottenstein Law Group LLP
3. DePuy Pinnacle Hip Implant Lawsuit News: Bernstein Liebhard LLP Comments on Johnson & Johnson Decision to Stop Metal-on-Metal Hip Sales
4. Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Applauds American Association for Justice Position on Metal-on-Metal Hip Replacement Regulation
5. MRI may predict adverse tissue reaction in metal-on-metal hip replacement patients
6. Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding Increased Metal Ion Levels May Predict Problems with Metal-on-Metal Hip Replacements
7. FDA Says Metal-on-Metal Hip Replacements Can Cause Soft-Tissue Damage, Rottenstein Law Group Reports
8. New Metal-on-Metal Hip Implant Study Emphasizes Importance of Patients’ Symptoms in Evaluating the Need for Hip Replacement Revisions, Bernstein Liebhard LLP Reports
9. Few Patients Should Get Metal-on-Metal Hip Implants, FDA Panel Says
10. FDA Probing Safety of Metal-on-Metal Hip Implants
11. Wright Conserve Hip Replacement Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of Amended Discovery Plan in Federal Wright Hip Litigation
Post Your Comments:
(Date:11/25/2015)... ... 2015 , ... The McHenry County law firm of Botto Gilbert Lancaster, ... Francisco J. Botto and Alex C. Wimmer. Attorneys Botto and Wimmer represented the claimant ... (2d) 130884WC. , According to court documents, Adcock testified that on May 10, 2010 ...
(Date:11/25/2015)... ... ... SCOTTSDALE, AZ) - Today, Dr. Todd C. Hobgood ... non-surgical treatments, announced the expansion of his private practice capabilities with the grand ... trained and nationally recognized for his natural approach, Dr. Todd Hobgood serves the ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted ... in Chicago, IL, UV Angel is evaluating the efficacy of its product and its ... units (totaling 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... scholarships for people struggling with eating disorders as a result of the $20,000 ... annual event, held at Fox Run Golf Club in Eureka, will help individuals ...
(Date:11/25/2015)... Davie, Florida (PRWEB) , ... November 25, 2015 ... ... PharmaTech LLC has announced that it has undertaken significant expansion of its current ... Florida. The investment is part of PharmaTech’s strategy to increase its manufacturing capacity ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)...  Amgen (NASDAQ: AMGN ) today announced the ... the United States (U.S.) Food and ... to Humira ® (adalimumab). Amgen believes this submission ... FDA and represents Amgen,s first BLA submission using the ... M.D., executive vice president of Research and Development at ...
(Date:11/25/2015)... Nov. 25, 2015  The American Academy of ... (ACOG), and the March of Dimes cheered today,s ... Our Infants Act of 2015 (S.799), which ... newborns born exposed to drugs, such as opioids, ... introduction, all three organizations have worked together leading ...
(Date:11/25/2015)... 2015  Linden Care, LLC, a retail specialty pharmacy ... patients suffering from chronic pain, said today that it ... Order (TRO) enjoining Express Scripts from unilaterally terminating the ... --> --> The company said ... options. --> --> ...
Breaking Medicine Technology: